Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




mRNA Molecules Localized and Quantified in Fixed Samples

By LabMedica International staff writers
Posted on 20 Sep 2011
A RNA visualization method allows simultaneous detection, localization, and quantification of individual mRNA molecules at the sub-cellular level in fixed samples.

By resolving in situ messenger RNA into clear focus, Stellaris fluorescence in situ hybridization (FISH) advances research in cancer, developmental biology, and pathology. More...
By enabling scientists to localize and count discrete molecules of mRNA using widefield fluorescence microscopy, the probes can lead also to streamlined studies in stem cell, pathology, transcription regulation, and neuroscience research.

Stellaris FISH is an effective tool for several key applications. For example, Stellaris probes are used to reveal up- and down- regulation of gene expression in drug screening studies. It can also be used to characterization tumors by correlating mRNA levels of known oncogenes.

Biosearch Technologies, Inc. (Biosearch; Novato, CA, USA), a supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, released the new product, Stellaris FISH Probes, which is currently manufactured on a custom basis. Stellaris FISH probes include software for optimum probe design. In addition, premade probe sets for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in human and mouse applications are available.

A probe set comprises multiple oligonucleotides with different sequences each with a fluorescent label that collectively bind along the same target transcript to produce a punctate signal. This direct detection method minimizes the possibility of false negatives and false positives. Furthermore, Stellaris FISH probes can bind to partially degraded target mRNAs making them well suited for formalin-fixed, paraffin-embedded (FFPE) tissue samples.

Stellaris FISH can also be combined with existing technologies such as quantitative polymerase chain reaction (qPCR), DNA FISH, immunohistochemistry (IHC), and western blotting to provide complementary information.

The Stellaris FISH technology follows a simple protocol, does not use exotic reagents, is inexpensive and platform-independent, offers same-day results, and is versatile toward many sample types and applications. Scientists may even label Stellaris FISH probes with different dyes, to allow for simultaneous multiplex detection of different RNA targets simultaneously. Scientists can address the stochastic nature of gene expression and visualize RNA through direct detection without isolation, purification, and amplification.

Related Links:

Biosearch Technologies, Inc.




Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.